Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Carbonylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112694430B enables efficient palladium-catalyzed production of pyrrolone intermediates with broad substrate scope and simplified processing for reliable pharmaceutical supply chains.
Patent CN112694430B enables one-step palladium-catalyzed synthesis of pyrrolone intermediates with high substrate tolerance enhancing supply chain reliability and reducing pharmaceutical manufacturing costs.
Patent CN119874591B introduces a mild nickel-catalyzed carbonylation method for high-purity pharmaceutical intermediates, enabling significant cost reduction and enhanced supply chain reliability in drug manufacturing.
Patent CN112125856A enables safe scalable production of high-purity quinazolinones eliminating toxic CO gas while improving cost efficiency for pharmaceutical applications.
Patent CN119823040A enables efficient synthesis of amido-DHIQK derivatives through palladium-catalyzed carbonylation, enhancing purity and supply chain reliability for pharma intermediates.
Patent CN117164534A enables efficient synthesis of acetamide-benzofuran derivatives via palladium catalysis. This method reduces manufacturing costs through simplified processes and enhances supply chain reliability for pharmaceutical intermediates.
Innovative Pd-catalyzed one-pot method enables high-purity 2-trifluoromethyl quinazolinone production with simplified manufacturing and enhanced supply chain reliability for pharmaceutical applications.
Patent CN112694430B introduces a novel palladium-catalyzed method for synthesizing pyrrolinone intermediates with high efficiency and substrate flexibility enabling reliable supply and cost reduction in pharmaceutical manufacturing
Novel palladium-catalyzed carbonylation method enables high-purity benzofuran derivatives with streamlined manufacturing and enhanced supply chain reliability for pharmaceutical applications.
Patent CN114751883B enables efficient one-step synthesis of high-purity benzofuran intermediates with significant cost reduction and supply chain reliability for pharma manufacturing.
Novel palladium-catalyzed carbonylation method enables high-yield synthesis with simplified supply chain and substantial cost reduction potential for pharmaceutical intermediates.
Novel palladium-catalyzed aminocarbonylation process enables scalable production of high-purity quinolinone derivatives with simplified workflow for pharmaceutical applications.
This patent introduces an efficient palladium-catalyzed route using nitroarenes as nitrogen sources enabling cost reduction and enhanced supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
This patent introduces a novel palladium-catalyzed carbonylation method for indolo[2,1a]isoquinoline compounds with simplified synthesis and enhanced supply chain reliability for pharmaceutical intermediates.
Patent CN112239384B introduces nickel-catalyzed thioester synthesis using sulfonyl chloride as sulfur source enabling high-purity pharmaceutical intermediates with enhanced supply chain reliability.
Patent CN119874591B introduces a mild nickel-catalyzed method for synthesizing diverse pyrrolidone derivatives enabling cost reduction and reliable supply chain for pharmaceutical manufacturing.
Patent CN119874591B introduces a nickel-catalyzed carbonylation method enabling high-purity synthesis with significant cost reduction and enhanced supply chain reliability for pharmaceutical intermediates.
Novel nickel-catalyzed carbonylation method enables high-yield indole synthesis with broad substrate tolerance, offering reliable supply chain solutions and cost reduction for pharmaceutical intermediates manufacturing.
Patent CN112480015B enables efficient one-pot synthesis of 2-trifluoromethyl quinazolinones via palladium catalysis, offering enhanced scalability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN112239436A enables efficient one-step production of bioactive furanone intermediates with simplified process design and substantial cost reduction potential for pharmaceutical supply chains.